19 July 2017, Sydney, Australia and Seoul, Korea - Asia Pacific CRO Novotech announced it has expanded its business offering to include clinical trial site management organization (SMO) services with the launch of Novotech SMO Korea Co. Limited in South Korea.
Novotech’s new business will train and provide clinical research coordinators (CRCs); as well as site management associates (SMAs) who will be able to support clinical trial principal investigators with site feasibility, patient recruitment and IRB support, based on Novotech’s SMO experience.
Site management organization (SMO) collaboration between principal investigators and sponsors is common within the US, EU, and Japan. Novotech launched its new SMO business in response to unmet industry need in South Korea. South Korea’s SMO industry is still quite young, with the legal foundations of the business model only being established through a revision in its Good Clinical Practice Guidelines in October 2016. Novotech also has several years of experience undertaking SMO projects in Taiwan.
Commenting on the new SMO offering Novotech CEO Dr. John Moller said, “South Korea is without a doubt a global leader within the clinical trials industry and we look forward to providing high quality SMO services to meet growing demand from South Korea.”
“With the launch of our new SMO business, Novotech is committed to providing our clients with high quality clinical trial support across all levels, from start to finish. As the demand for education and quality assurance for clinical trial staff grows, Novotech is not only able to offer clinical service as a CRO; we are now also able to provide a comprehensive range of specialized CRC and SMA services. Through our SMO operations, we will provide a strong supply of CRC and SMA personnel to fulfil South Korea’s industry needs,” said Novotech Executive Director for Asia Operations Dr. Yooni Kim.
For RFP enquiries: Please fill out the form available at www.novotech-cro.com/contact-us-0
Corporate and media enquiries
Marketing & Communications Manager Justine Lamond
Ph: +61 2 8569 1458
Email: communications@novotech-cro.com
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.